Boardroom Alpha
Research library
SPACs · Jul 30, 2026

SPAC Market Update July 30, 2026: BCAR-Exascale Vote Approved After 26,865,211 Shares Redeemed

D BORAL ARC ACQUISITION I CORP (BCAR) shareholders approved the Exascale Labs Inc combination on July 30, 2026 after 26,865,211 shares were redeemed; the reported vote data did not include a dollar amount removed from trust. Separately, Alchemy Investments…

SPAC IPO Update — July 30, 2026

No SPAC IPOs priced on July 30, 2026; July MTD now stands at 16 IPOs totaling $3.41B over 30 sessions.

SPAC IPO Count

Monthly IPOs (last 13 months)
Latest: 16Prior: 19MoM: -3
13
Jul ’25
8
Aug ’25
14
Sep ’25
14
Oct ’25
10
Nov ’25
22
Dec ’25
24
Jan ’26
27Peak
Feb ’26
11
Mar ’26
16
Apr ’26
20
May ’26
19
Jun ’26
16
Jul ’26
Source: Boardroom Alpha
IPO Activity SnapshotMonth-to-date: 16 IPOs ($3.41B) vs. first 30 days of last month 19 ($4.02B) · 12-mo avg: 16/mo
$ totals include underwriter over-allotment.
New SPAC IPOs
Date Ticker Issuer IPO Size Trust Funding
Jul 28 CATL CATALYST ACQUISITION CORP $200M 100.0%
Jul 24 MTAK MARKET TECHNOLOGY ACQUISITION CORP $200M  $5M overallotment 100.5%
Jul 24 PLCI PELICAN ACQUISITION II CORP $75M 101.0%
Jul 21 BRTM B&R TECHNOLOGY MERGER CORP $325M 100.0%
Jul 21 NCO SOUTHERN CROSS ACQUISITION I CORP $100M  $15M overallotment 100.0%
Source: Boardroom Alpha

Daily SPAC Update — July 30, 2026

SPAC VOTE RESULTS
D BORAL ARC ACQUISITION I CORP (BCAR) * Deal Approved with Exascale Labs Inc26,865,211 redeemed

SPAC DEAL & EXTENSION VOTES SET
Alchemy Investments Acquisition Corp 1 (ALCYF) * EXTENSION VOTE SET: September 1, 2026 * trust $12.41

EXTENSION VOTES
CARTESIAN GROWTH CORP II (RENEF)vote July 30, 2026 -> extend from August 5, 2026 to August 5, 2027

SPAC EXTENSIONS
CONSTELLATION ACQUISITION CORP I (CSTAF) * Extension FilingConstellation Acquisition Corp I extends its initial business combination deadline to August 29, 2026 via a $5,000 unsecured sponsor loan, due at closing.
RISING DRAGON ACQUISITION CORP (RDAC) * Extension FilingRising Dragon issued notes to extend the merger deadline to Aug 15, 2026; zero-interest and convertible at $10.

SEPARATE WARRANTS/RIGHTS
August 3: OCEAN CAPITAL ACQUISITION CORP (OCAC)
July 31: SOUTHERN CROSS ACQUISITION I CORP (NCO)
July 31: COLUMBUS CIRCLE CAPITAL CORP III (CCCT)
July 31: FUTUREWAVE ACQUISITION CORP (FWAC)
July 30: SNOW ROTHSCHILD ACQUISITION CORP (ISNR)
July 27: INTERPRIVATE INVESTMENT PARTNERS V INC (IPV)
July 27: LONG TABLE GROWTH CORP (LTGR)
July 27: FUTURECORP SPACE ACQUISITION 1 (FTRA)

OTHER SPAC NEWS
APEX TREASURY CORP (APXT) * Media TranscriptTECfusions and Apex announce SPAC merger to become an AI infrastructure platform, backed by $35M pipe and $345M trust.
GRAF GLOBAL CORP (TONT) * Media TranscriptIce Cube discusses the Graf-BIG3 business combination; deal valued at nearly $300M. Details on Form S-4/proxy plans forthcoming.
WESTIN ACQUISITION CORP (WSTN) * Merger Agreement

SPAC LIQUIDATIONS
CHURCHILL CAPITAL CORP IX (CCIX) -> Liquidation on July 28

SPAC DEALS ANNOUNCED
July 27 | Research Alliance Corp III (RACC) + Oak Hill BioOak Hill Bio is a clinical-stage biotechnology company that develops therapeutics for rare diseases that have been deprioritized by pharmaceutical companies. Its lead program, rugonersen (OHB-724), is an investigational antisense oligonucleotide in Phase 3 clinical development for Angelman syndrome, a neurodevelopmental disorder lacking approved disease-modifying therapies. The company operates as a subsidiary of Oak Hill Bio Holdings and was formed in 2024.
July 27 | Cartesian Growth Corp II (RENEF) + InoBatInoBat is a European manufacturer of battery energy storage systems and a cell development platform, based in Slovakia. It designs, manufactures, and deploys utility-scale battery energy storage systems through its BESSMONT product line from its facility in Voderady, targeting industrial and utility customers. The company is involved in partnerships for next-generation cell technology and participates in a gigafactory joint venture to support the European battery supply chain.

SPAC Movers — July 30, 2026

YESTERDAY’S TOP SPAC GAINERS
Company Ticker Change Price Stage
RESEARCH ALLIANCE CORP III RACC 19.2% $ 16.50 Announced
KEEN VISION ACQUISITION CORP KVAC 7.0% $ 13.38 Announced
RISING DRAGON ACQUISITION CORP RDAC 6.9% $ 6.49 Announced
FUTURE VISION II ACQUISITION CORP FVN 4.8% $ 9.33 Announced
INFLECTION POINT ACQUISITION CORP III IPCX 4.7% $ 9.35 Announced
YESTERDAY’S TOP SPAC LOSERS
Company Ticker Change Price Stage
DIGITAL ASSET ACQUISITION CORP DAAQ -33.8% $ 6.89 Announced
D BORAL ARC ACQUISITION I CORP BCAR -26.5% $ 4.16 Announced
BLUEPORT ACQUISITION LTD BPAC -9.9% $ 8.36 Announced
GENERAL PURPOSE ACQUISITION CORP GPAC -9.0% $ 10.01 Pre-Deal
CHURCHILL CAPITAL CORP XI CCXI -6.9% $ 13.52 Announced
Source: Boardroom Alpha market data

Frequently Asked Questions

  • What happened in the BCAR merger vote?
    D BORAL ARC ACQUISITION I CORP (BCAR) shareholders approved the Exascale Labs Inc deal. The vote data showed 26,865,211 shares redeemed and did not report a dollar amount removed from trust.
  • What extension vote was set today?
    Alchemy Investments Acquisition Corp 1 (ALCYF) set September 1, 2026 for an extension vote, the only extension vote set today.
  • How many SPAC IPOs priced in July 2026 through July 30?
    16 SPAC IPOs priced for $3.41B through July 30, 2026, compared with 19 IPOs for $4.02B over the same span in June 2026.
  • Which SPAC merger announcements appeared in the last 5 days?
    Research Alliance Corp III (RACC) announced Oak Hill Bio, and Cartesian Growth Corp II (RENEF) announced InoBat; there were 2 deal announcements in the last 5 days.


Get it in your inbox

The Daily SPAC Update in your inbox

Every IPO, vote, and DeSPAC close — analyzed daily for finance professionals.

ShareXLinkedIn

Published Jul 30, 2026

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer